Hiroshi Kida Selected Research

Influenza in Birds (Avian Flu)

1/2022	Characterization of the In Vitro and In Vivo Efficacy of Baloxavir Marboxil against H5 Highly Pathogenic Avian Influenza Virus Infection.
1/2021	Efficacy of a Cap-Dependent Endonuclease Inhibitor and Neuraminidase Inhibitors against H7N9 Highly Pathogenic Avian Influenza Virus Causing Severe Viral Pneumonia in Cynomolgus Macaques.
10/2020	Cell-penetrating peptide-mediated cell entry of H5N1 highly pathogenic avian influenza virus.
4/2020	E190V substitution of H6 hemagglutinin is one of key factors for binding to sulfated sialylated glycan receptor and infection to chickens.
1/2020	Low replicative fitness of neuraminidase inhibitor-resistant H7N9 avian influenza a virus with R292K substitution in neuraminidase in cynomolgus macaques compared with I222T substitution.
1/2020	Efficacy of Neuraminidase Inhibitors against H5N6 Highly Pathogenic Avian Influenza Virus in a Nonhuman Primate Model.
1/2019	Inhibition of avian-origin influenza A(H7N9) virus by the novel cap-dependent endonuclease inhibitor baloxavir marboxil.
1/2019	Evaluation of a rapid isothermal nucleic acid amplification kit, Alere™ i Influenza A&B, for the detection of avian influenza viruses.
5/2017	Antigenic diversity of H5 highly pathogenic avian influenza viruses of clade 2.3.4.4 isolated in Asia.
3/2017	Therapeutic efficacy of peramivir against H5N1 highly pathogenic avian influenza viruses harboring the neuraminidase H275Y mutation.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroshi Kida Research Topics

Disease

55	Infections 05/2022 - 07/2002
46	Influenza in Birds (Avian Flu) 01/2022 - 08/2002
44	Human Influenza (Influenza) 05/2022 - 08/2002
17	Neoplasms (Cancer) 07/2022 - 10/2010
15	Virus Diseases (Viral Diseases) 05/2022 - 01/2008
11	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 07/2021 - 08/2011
10	Lung Diseases (Lung Disease) 01/2022 - 01/2013
10	Inflammation (Inflammations) 10/2021 - 05/2011
9	Chronic Obstructive Pulmonary Disease (COPD) 02/2022 - 03/2006
8	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 09/2018 - 10/2010
7	Idiopathic Interstitial Pneumonias 01/2022 - 10/2014
7	Fibrosis (Cirrhosis) 10/2020 - 07/2002
6	Lung Neoplasms (Lung Cancer) 07/2022 - 01/2013
5	Pneumonia (Pneumonitis) 01/2022 - 05/2009
5	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 07/2012
5	Idiopathic Pulmonary Fibrosis 01/2022 - 02/2004
5	Disease Progression 01/2021 - 10/2010
5	Neoplasm Metastasis (Metastasis) 02/2017 - 10/2010
5	Diarrhea 05/2015 - 02/2008
4	Pulmonary Alveolar Proteinosis 01/2021 - 11/2014
4	Respiratory Insufficiency (Respiratory Failure) 05/2020 - 11/2014
4	Classical Swine Fever (Swine Fever) 01/2020 - 08/2012
4	Adenocarcinoma of Lung 11/2019 - 01/2012
3	Asthma (Bronchial Asthma) 12/2021 - 03/2006
3	Emphysema 01/2021 - 05/2011
3	Pulmonary Fibrosis (Fibrosing Alveolitis) 11/2014 - 07/2002
2	Body Weight (Weight, Body) 01/2021 - 11/2010
2	Viral Pneumonia 01/2021 - 01/2017
2	Bronchiectasis 10/2020 - 06/2020
2	Thrombocytopenia (Thrombopenia) 07/2020 - 01/2013
2	Autoimmune Diseases (Autoimmune Disease) 02/2020 - 01/2017
2	Sarcoidosis (Schaumann Disease) 02/2020 - 01/2017
2	Lung Injury 01/2020 - 01/2015

Drug/Important Bio-Agent (IBA)

41	VaccinesIBA 05/2022 - 08/2002
15	Proteins (Proteins, Gene)FDA Link 01/2021 - 11/2006
14	Hemagglutinins (Hemagglutinin)IBA 11/2021 - 08/2002
13	Neuraminidase (Sialidase)IBA 05/2022 - 07/2003
12	Antiviral Agents (Antivirals)IBA 01/2022 - 04/2002
8	Influenza Vaccines (Influenza Vaccine)FDA Link 05/2022 - 09/2008
8	AntibodiesIBA 05/2022 - 08/2002
8	CytokinesIBA 10/2021 - 07/2002
8	AntigensIBA 01/2020 - 01/2005
6	Biomarkers (Surrogate Marker)IBA 01/2022 - 12/2018
6	TetraspaninsIBA 01/2018 - 05/2009
6	Pharmaceutical PreparationsIBA 01/2015 - 06/2011
5	Ether (Diethyl Ether)IBA 01/2022 - 06/2008
5	AutoantibodiesIBA 01/2022 - 11/2014
5	Oseltamivir (Tamiflu)FDA Link 01/2022 - 11/2011
5	ChemokinesIBA 01/2021 - 06/2012
5	peramivirIBA 03/2017 - 11/2010
5	Monoclonal AntibodiesIBA 01/2017 - 01/2006
5	Amino Acids FDA Link 02/2016 - 12/2004
4	Clostridium perfringens epsilon-toxinIBA 02/2022 - 01/2020
4	Oxygen (Dioxygen)IBA 02/2022 - 10/2014
4	Immunoglobulin A (IgA)IBA 01/2022 - 01/2015
4	Formaldehyde (Formol)FDA Link 01/2022 - 07/2003
4	baloxavirIBA 01/2022 - 01/2019
4	Biological ProductsIBA 10/2021 - 02/2004
4	ThrombomodulinIBA 01/2021 - 01/2013
4	Viral RNAIBA 01/2021 - 03/2006
4	Interferon Type IIBA 01/2016 - 10/2010
3	Immunoglobulin E (IgE)IBA 11/2021 - 07/2005
3	Peptides (Polypeptides)IBA 11/2021 - 01/2012
3	Pancreatic Elastase (Elastase)IBA 01/2021 - 05/2011
3	EndonucleasesIBA 01/2021 - 12/2018
3	Neutralizing AntibodiesIBA 12/2020 - 08/2009
3	Polysaccharides (Glycans)IBA 04/2020 - 02/2013
3	N-Acetylneuraminic Acid (Sialic Acid)IBA 04/2020 - 11/2010
3	Bleomycin (Blenoxane)FDA LinkGeneric 01/2020 - 07/2002
3	Interleukin-6 (Interleukin 6)IBA 01/2019 - 05/2003
3	ErbB Receptors (EGF Receptor)IBA 02/2017 - 07/2012
3	Irinotecan (Camptosar)FDA LinkGeneric 01/2017 - 04/2012
3	Erlotinib Hydrochloride (CP 358,774)FDA Link 11/2013 - 04/2012
3	Viral AntigensIBA 01/2006 - 11/2003
2	Phosphates (Orthophosphate)IBA 07/2022 - 01/2022
2	Viral Envelope ProteinsIBA 11/2021 - 07/2003
2	Zanamivir (Relenza)FDA Link 11/2021 - 01/2021
2	Bevacizumab (Avastin)FDA Link 07/2021 - 01/2013
2	Interferon-alpha (Interferon Alfa)IBA 01/2021 - 01/2020
2	Acetaminophen (Paracetamol)FDA LinkGeneric 01/2021 - 11/2014
2	Surface-Active Agents (Surfactants)IBA 01/2021 - 02/2004
2	C-Reactive ProteinIBA 01/2021 - 02/2004
2	Oncogene Proteins (Oncogene Protein)IBA 01/2021 - 08/2011
2	Detergents (Detergent)IBA 01/2021 - 01/2019
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2021 - 03/2010
2	Interleukin-13IBA 01/2021 - 01/2017
2	AcidsIBA 12/2020 - 06/2020
2	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2020 - 01/2019
2	Immunosuppressive Agents (Immunosuppressants)IBA 01/2020 - 01/2019
2	EnzymesIBA 01/2020 - 02/2004
2	Insulin (Novolin)FDA Link 01/2020 - 02/2004
2	pembrolizumabIBA 11/2019 - 01/2019
2	Immune Checkpoint InhibitorsIBA 11/2019 - 01/2019
2	Therapeutic UsesIBA 01/2019 - 01/2017
2	NivolumabIBA 01/2019 - 10/2018
2	SteroidsIBA 01/2019 - 01/2017

Therapy/Procedure

23	Therapeutics 12/2021 - 02/2002
8	Drug Therapy (Chemotherapy) 01/2022 - 02/2002
2	Immunotherapy 07/2022 - 01/2018
2	Chemoradiotherapy 01/2019 - 01/2019